Cover Image

Artificial intelligence in drug discovery: A comprehensive review with a case study on hyperuricemia, gout arthritis, and hyperuricemic nephropathy

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Su, Junwei, Xin, Cheng, Shang, Ao, Wu, Shan, Xie, Zhenzhen, Xiong, Ruogu, Xu, Xiaoyu, Zhang, Cheng, Chen, Guang, Chan, Yau-Tuen, Tang, Guoyi, Wang, Ning, Xu, Yong, Feng, Yibin
Format:	Preprint
Published:	2025
Subjects:	Artificial Intelligence Quantitative Methods
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Current updates for hyperuricemia and gout in age‐related macular degeneration
by: Hung‐Liang Pai, et al.
Published: (2024)

Artificial intelligence streamlines scientific discovery of drug–target interactions
by: Yuxin Yang, et al.
Published: (2025)

Natural Products as the Modulators of Gut Microbiota: A Pool for the Development of New Treatment Against Obesity?
by: Hongchao Yuan, et al.
Published: (2026)

Comparative Efficacy of Various Exercise Types on Cancer‐Related Fatigue for Cancer Survivors: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
by: Shichen Zhou, et al.
Published: (2025)

Noni ( Morinda citrifolia L.) Fermented Juice Inhibits Tumor Progression of Breast Cancer Angiogenesis Through Suppressing NF‐κB Signaling
by: Baijian Wu, et al.
Published: (2026)

Luteolin ameliorates hyperuricemic nephropathy by activating urate excretion and Nrf2/HO‐1/NQO1 antioxidant pathways in mice
by: Huifan Yu, et al.
Published: (2024)

Herbal remedies in the management of hyperuricemia and gout: A review of in vitro, in vivo and clinical evidences
by: Mohamad Fawzi Mahomoodally, et al.
Published: (2024)

A comprehensive review of molecular optimization in artificial intelligence‐based drug discovery
by: Yuhang Xia, et al.
Published: (2024)

Investigation of resveratrol as a xanthine oxidase inhibitor: Mechanistic insights and therapeutic implications for gout and hyperuricemia
by: Jianmin Chen, et al.
Published: (2024)

Comparison of the anti‐hyperuricemia effects of several cinnamic acid derivatives
by: Jianmei Sun, et al.
Published: (2025)

Comment on serum urate‐lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: A randomized, double‐blind, placebo‐controlled, dose‐finding trial
by: Tai‐Ming Hsu, et al.
Published: (2024)

Analysis of dietary vitamin C intake levels and the risk of hyperuricemia and gout based on cross‐sectional studies and bi‐directional Mendelian randomization
by: Zi‐Ning Peng, et al.
Published: (2024)

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction
by: Ryutaro Iwama, et al.
Published: (2024)

Gross and cytological appearance of oral gout in a crested gecko ( Correlophus ciliatus ) with end‐stage nephropathy
by: I. Alvarado‐Hidalgo, et al.
Published: (2026)

The first Dirichlet eigenvalue and the width
by: Xu, Guoyi
Published: (2024)

Integral of scalar curvature on manifolds with a pole
by: Xu, Guoyi
Published: (2023)

Rheumatoid arthritis and PLA2R‐associated mebranous nephropathy. Cause or coincidence?
by: Lara Perea‐Ortega, et al.
Published: (2024)

Data-centric challenges with the application and adoption of artificial intelligence for drug discovery
by: Ghislat, Ghita, et al.
Published: (2024)

Endogenous opioids participation in the effect of Rosmarinus officinalis L. in the visceral, inflammatory and gout arthritis nociception in rodents
by: Ana Laura Martínez
Published: (2013)

Application of artificial intelligence in microbial drug discovery: Unlocking new frontiers in biotechnology.
by: Mulat, Mulugeta, et al.
Published: (2025)

Pathogenesis of gout: Exploring more therapeutic target
by: Niqin Xiao, et al.
Published: (2024)

Artificial intelligence in rheumatoid arthritis research: A bibliometric analysis from 2004 to 2023
by: Yang Liu, et al.
Published: (2024)

Drug discovery guided by maximum drug likeness
by: Zhu, Hao-Yu, et al.
Published: (2025)

Artificial intelligence for adaptive neuromodulation in drug‐resistant epilepsy
by: Amir Hossein Daraie, et al.
Published: (2026)

Tophaceous gout
by: Tyler B. Larsen, et al.
Published: (2025)

Tophaceous gout
by: Durga Neupane, et al.
Published: (2024)

The first Neumann eigenvalue and the width
by: Wang, Haibin, et al.
Published: (2024)

The rigidity of eigenfunctions' gradient estimates
by: Xu, Guoyi, et al.
Published: (2024)

Extrinsic Bonnet-Myers Theorem and almost rigidity
by: Li, Weiying, et al.
Published: (2024)

A universal programmable Gaussian Boson Sampler for drug discovery
by: Yu, Shang, et al.
Published: (2022)

A Trace-Path Integral Formula over Function Fields
by: Cheng, Yan Yau
Published: (2025)

Commensal Enterococcus faecalis W5 ameliorates hyperuricemia and maintains the epithelial barrier in a hyperuricemia mouse model
by: Xin Liu, et al.
Published: (2024)

Immunoadsorption combined with antirheumatic drugs in the treatment of psoriatic arthritis with rheumatoid arthritis: A case report
by: Li Cui, et al.
Published: (2024)

Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature
by: Odysseas P. Chatzipanagiotou, et al.
Published: (2024)

Quantum QSAR for drug discovery
by: Giraldo, Alejandro, et al.
Published: (2025)

Human cardiomyocytes for drug discovery
by: Diogo Gonçalves Biagi
Published: (2018)

Social identity in trusting artificial intelligence agents: Evidence from lab and online experiments
by: Yanqi Sun, et al.
Published: (2024)

The impact of gout flare triggers: A qualitative interview study of people with gout
by: Julia Rennie, et al.
Published: (2024)

Strategic approaches to the discovery of biologically active indole derivatives: a comprehensive review.
by: Gao, Gui-Ping, et al.
Published: (2026)

Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathy
by: Yidong Zhu, et al.
Published: (2024)